Theriva Biologics (TOVX) Shares Outstanding (Entity) (2010 - 2026)
Theriva Biologics (TOVX) reported Shares Outstanding (Entity) of 45.89 million for Q2 2026, up 579.6% from 6.75 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
For FY2025, Theriva Biologics posted Shares Outstanding (Entity) of 12.14 million, up 800.6% from FY2024.
- Shares Outstanding (Entity) has increased for seven consecutive years, with a five-year compound annual growth rate of 175.8% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 1.35 million in FY2024 (+96.5%), 685,922 in FY2023 (+13.4%), 604,962 in FY2022 (+14.5%) and 528,170 in FY2021 (+594.5%).
- The high point for year-over-year Shares Outstanding (Entity) in five years was Q3 2025 (growth of 808.4%); the low point was Q1 2023 (a decline of 4.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 45.89 million (Q1 2026), 12.14 million (Q4 2025) and 10.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.00 Bn | 1,140.58 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 639.12 Bn | 557.64 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 502.23 Bn | 475.34 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 375.29 Bn | 329.67 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.99 Bn | 266.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.36 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.24 Bn | 197.64 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 193.36 Bn | 167.56 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Theriva Biologics | 8.81 Mn | -37.54 Mn | - | 45.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.89 Mn |
| Mar 31, 2026 | 45.89 Mn |
| Dec 31, 2025 | 12.14 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 6.75 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 895,726.00 |
| Mar 31, 2024 | 685,922.00 |
| Dec 31, 2023 | 685,922.00 |
| Sep 30, 2023 | 681,711.00 |
| Jun 30, 2023 | 681,671.00 |
| Mar 31, 2023 | 604,962.00 |
| Dec 31, 2022 | 604,962.00 |
| Sep 30, 2022 | 633,762.00 |
| Jun 30, 2022 | 633,762.00 |
| Mar 31, 2022 | 633,751.00 |
| Dec 31, 2021 | 528,170.00 |
| Sep 30, 2021 | 528,170.00 |
API Access
Theriva Biologics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();